LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 41.11 | 27.76 | 3695 | 3331 | 1.1091 | 1.0302 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 41.11 | 27.76 | 3728 | 3331 | 1.1190 | 1.0328 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 42.81 | 27.76 | 543 | 3596 | 0.1510 | 0.5277 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 42.81 | 27.76 | 4464 | 3596 | 1.2413 | 1.0626 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 42.81 | 27.76 | 3997 | 3596 | 1.1114 | 1.0303 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 42.81 | 27.76 | 4043 | 3596 | 1.1242 | 1.0336 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 44.52 | 27.76 | 654 | 3884 | 0.1684 | 0.5577 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 44.52 | 27.76 | 4703 | 3884 | 1.2108 | 1.0544 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 44.52 | 27.76 | 4280 | 3884 | 1.1019 | 1.0274 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 44.52 | 27.76 | 4315 | 3884 | 1.1109 | 1.0297 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 46.22 | 27.76 | 637 | 4125 | 0.1544 | 0.5438 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 46.22 | 27.76 | 5060 | 4125 | 1.2267 | 1.0574 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 46.22 | 27.76 | 4489 | 4125 | 1.0882 | 1.0236 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 46.22 | 27.76 | 4559 | 4125 | 1.1052 | 1.0279 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 47.93 | 27.76 | 742 | 4421 | 0.1678 | 0.5670 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 47.93 | 27.76 | 5440 | 4421 | 1.2304 | 1.0575 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 47.93 | 27.76 | 4891 | 4421 | 1.1062 | 1.0278 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 47.93 | 27.76 | 4933 | 4421 | 1.1157 | 1.0302 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 49.63 | 27.76 | 861 | 4818 | 0.1787 | 0.5867 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 49.63 | 27.76 | 5948 | 4818 | 1.2345 | 1.0574 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 49.63 | 27.76 | 5089 | 4818 | 1.0562 | 1.0148 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 49.63 | 27.76 | 5121 | 4818 | 1.0629 | 1.0165 | MN20160318_Q01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 51.33 | 27.76 | 1020 | 5117 | 0.1993 | 0.6142 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 51.33 | 27.76 | 6275 | 5117 | 1.2263 | 1.0549 | MN20160318_Q01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 51.33 | 27.76 | 5543 | 5117 | 1.0832 | 1.0214 | MN20160318_Q01 | K07 |